CD274 and neoplasm: Subsequent trials have also revealed that the combination of 5-FU and oxaliplatin decreased the expression of immune checkpoints PD-L1 and PD-L2 on the surface of DCs, promoting DC maturation in tumor-bearing mice (Hong et al., 2018).